| The human coronavirus HCoV-229E S-protein structure and receptor binding Z Li, ACA Tomlinson, AHM Wong, D Zhou, M Desforges, PJ Talbot, ... Elife 8, e51230, 2019 | 206 | 2019 |
| Receptor-binding loops in alphacoronavirus adaptation and evolution AHM Wong, ACA Tomlinson, D Zhou, M Satkunarajah, K Chen, C Sharon, ... Nature communications 8 (1), 1735, 2017 | 93 | 2017 |
| Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS CJ Schulze, KJ Seamon, Y Zhao, YC Yang, J Cregg, D Kim, A Tomlinson, ... Science 381 (6659), 794-799, 2023 | 41 | 2023 |
| Discovery of RMC-5552, a selective bi-steric inhibitor of mTORC1, for the treatment of mTORC1-activated tumors GL Burnett, YC Yang, JB Aggen, J Pitzen, MK Gliedt, CM Semko, ... Journal of medicinal chemistry 66 (1), 149-169, 2022 | 23 | 2022 |
| Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy M Holderfield, BJ Lee, J Jiang, A Tomlinson, KJ Seamon, A Mira, ... Nature, 1-8, 2024 | 10 | 2024 |
| A first-in-class tri-complex KRASG13C(ON) inhibitor validates therapeutic targeting of KRASG13Cand drives tumor regressions in preclinical models CJ Schulze, J Cregg, KJ Seamon, YC Yang, Z Wang, LS Garrenton, ... Cancer Research 82 (12_Supplement), 3598-3598, 2022 | 5 | 2022 |
| Translational and therapeutic evaluation of RAS-GTP inhibition by RMC-6236 in RAS-driven cancers J Jiang, L Jiang, BJ Maldonato, Y Wang, M Holderfield, I Aronchik, ... Cancer Discovery 14 (6), 994-1017, 2024 | 4 | 2024 |
| Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy M Singh, M Holderfield, B Lee, J Jiang, A Tomlinson, K Seamon, A Mira, ... | 4 | 2023 |
| Abstract ND07: Discovery of RMC-6291, a tri-complex KRASG12C(ON) inhibitor J Cregg, RJ Nichols, YC Yang, CJ Schulze, Z Wang, R Dua, J Jiang, ... Cancer Research 83 (7_Supplement), ND07-ND07, 2023 | 2 | 2023 |
| RM-046, a first-in-class, mutant-selective, and oral KRASQ61H(ON) inhibitor that drives tumor regression in preclinical models and validates KRASQ61H as a … YC Yang, S Thompson, D Montgomery, AJ Quiñones, X Wei, B Madej, ... Cancer Research 83 (7_Supplement), 1598-1598, 2023 | 1 | 2023 |
| Abstract B137: Selective inhibition of the active state of KRASG12V with the non-covalent, tri-complex inhibitor RM-048 BJ Lee, J Cregg, A Edwards, J Chen, A Eriksson, E Tonogai, A Tomlinson, ... Molecular Cancer Therapeutics 22 (12_Supplement), B137-B137, 2023 | | 2023 |
